Latest news
Nuvectis Pharma Inc (NVCT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 17:47:55 GMTStreetWatch: Nuvectis Pharma Eyes $9.8 Billion Oral PNH Market Wi - The National Law ReviewThe National Law Review · Fri, 07 Aug 2026 14:49:54 GMTSoleus group (NVCT) discloses 1.65M-share, 5.1% Nuvectis Pharma stake - Stock TitanStock Titan · Thu, 06 Aug 2026 15:20:09 GMT(NVCT) Movement Within Algorithmic Entry Frameworks - Stock Traders DailyStock Traders Daily · Thu, 06 Aug 2026 11:46:01 GMTLucid Capital Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Raises Target Price to $34 - MoomooMoomoo · Wed, 05 Aug 2026 10:35:01 GMTNuvectis Pharma (NASDAQ:NVCT) Shares Gap Down After Earnings Miss - MarketBeatMarketBeat · Tue, 04 Aug 2026 14:49:11 GMTNuvectis Pharma Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Tue, 04 Aug 2026 13:35:23 GMTNuvectis Pharma, Inc. 2Q 2026: Net loss $(7.02)M, EPS $(0.30) — 10-Q Summary - TradingViewTradingView · Tue, 04 Aug 2026 13:11:01 GMT